How to buy Obalon Therapeutics stock | $1.655

Obalon Therapeutics, Inc is a medical devices business based in the US. Obalon Therapeutics shares (OBLN) are listed on the NASDAQ and all prices are listed in US Dollars. Obalon Therapeutics employs 2 staff and has a trailing 12-month revenue of around USD$2.3 million.

How to buy shares in Obalon Therapeutics

1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
3. Search for Obalon Therapeutics. Find the stock by name or ticker symbol: OBLN. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Obalon Therapeutics reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. At last close price of USD$1.655, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Obalon Therapeutics, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of Obalon Therapeutics. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Obalon Therapeutics share price

Use our graph to track the performance of OBLN stocks over time.

Obalon Therapeutics shares at a glance

• Key figures

Information last updated 2020-12-02.

Latest market close	USD$1.655
52-week range	USD$0.62 - USD$2.14
50-day moving average	USD$0.9097
200-day moving average	USD$0.8527
Wall St. target price	USD$0.75
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	USD$-13.267

Buy Obalon Therapeutics shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

Is it a good time to buy Obalon Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Obalon Therapeutics, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Obalon Therapeutics price performance over time

Historical closes compared with the close of $1.655 from 2020-12-09

1 week (2021-01-08)	13.36%
1 month (2020-12-17)	8.17%
3 months (2020-10-15)	93.34%
6 months (2020-07-15)	113.82%

1 year (2020-01-15)	-13.80%
2 years (2019-01-15)	-3.22%
3 years (2018-01-15)	N/A
5 years (2016-01-15)	N/A

Obalon Therapeutics financials

Revenue TTM	USD$2.3 million
Gross profit TTM	USD$384,000
Return on assets TTM	-48.97%
Return on equity TTM	-122.54%
Profit margin	0%
Book value	$0.762
Market capitalisation	USD$10.3 million

TTM: trailing 12 months

Shorting Obalon Therapeutics shares

There are currently 355,994 Obalon Therapeutics shares held short by investors – that's known as Obalon Therapeutics's "short interest". This figure is 1.1% up from 352,189 last month.

There are a few different ways that this level of interest in shorting Obalon Therapeutics shares can be evaluated.

Obalon Therapeutics's "short interest ratio" (SIR)

Obalon Therapeutics's "short interest ratio" (SIR) is the quantity of Obalon Therapeutics shares currently shorted divided by the average quantity of Obalon Therapeutics shares traded daily (recently around 87253.431372549). Obalon Therapeutics's SIR currently stands at 4.08. In other words for every 100,000 Obalon Therapeutics shares traded daily on the market, roughly 4080 shares are currently held short.

However Obalon Therapeutics's short interest can also be evaluated against the total number of Obalon Therapeutics shares, or, against the total number of tradable Obalon Therapeutics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Obalon Therapeutics's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 Obalon Therapeutics shares in existence, roughly 50 shares are currently held short) or 0.0557% of the tradable shares (for every 100,000 tradable Obalon Therapeutics shares, roughly 56 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Obalon Therapeutics.

Find out more about how you can short Obalon Therapeutics stock.

Obalon Therapeutics share dividends

We're not expecting Obalon Therapeutics to pay a dividend over the next 12 months.

Have Obalon Therapeutics's shares ever split?

Obalon Therapeutics's shares were split on a 1:10 basis on 25 July 2019. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Obalon Therapeutics shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Obalon Therapeutics shares which in turn could have impacted Obalon Therapeutics's share price.

Obalon Therapeutics share price volatility

Over the last 12 months, Obalon Therapeutics's shares have ranged in value from as little as $0.62 up to $2.14. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Obalon Therapeutics's is -0.9288. This would suggest that Obalon Therapeutics's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Obalon Therapeutics has bucked the trend.

Obalon Therapeutics overview

Obalon Therapeutics, Inc., a vertically integrated medical device company, focuses on developing and commercializing medical devices to treat people with obesity. The company offers the Obalon Balloon System designed to provide weight loss in patients with obesity. Its Obalon Balloon System comprises of a swallow able capsule that contains an inflatable balloon attached to a microcatheter; the Obalon Navigation System console, which is a combination of hardware and software used to track and display the location of the balloon during placement; the Obalon Touch Inflation Dispenser, which is a semi-automated, hand-held inflation device used to inflate the balloon once it is placed; and a disposable canister filled with mixture of gas. As of February 27, 2020, it had three company-managed retail treatment centers in California. Obalon Therapeutics, Inc. was founded in 2008 and is headquartered in Carlsbad, California.

Frequently asked questions

• What percentage of Obalon Therapeutics is owned by insiders or institutions?

  Currently 3.923% of Obalon Therapeutics shares are held by insiders and 44.309% by institutions.

• How many people work for Obalon Therapeutics?

  Latest data suggests 2 work at Obalon Therapeutics.

• When does the fiscal year end for Obalon Therapeutics?

  Obalon Therapeutics's fiscal year ends in December.

• Where is Obalon Therapeutics based?

  Obalon Therapeutics's address is: 5421 Avenida Encinas, Carlsbad, CA, United States, 92008-4410

• What is Obalon Therapeutics's ISIN number?

  Obalon Therapeutics's international securities identification number is: US67424L2097

• What is Obalon Therapeutics's CUSIP number?

  Obalon Therapeutics's Committee on Uniform Securities Identification Procedures number is: 67424L100